Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region.
In the Middle East and North Africa (MENA) region, cancer has many epidemiologic and clinical features that are different from those in the rest of the world. Additionally, the region has a relatively young population and large disparities in the availability of resources at diagnostic and treatment levels. A critical need exists for regional guidelines on cancer care, including those for lymphoid malignancies. A panel of lymphoma experts from MENA reviewed the 2009 version of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) on Non-Hodgkin's Lymphoma and Hodgkin Lymphoma and suggested modifications for the region that were discussed with the United States NCCN Lymphoma Panels. This article presents the consensus recommendations.
Bazarbachi
Ali
A
Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon. bazarbac@aub.edu.lb
Azim
Hamdy A
HA
Alizadeh
Hussain
H
Aljurf
Mahmoud
M
Barista
Ibrahim
I
Chaudhri
Naeem A
NA
Fahed
Zahira
Z
Fahmy
Omar A
OA
Ghavamzadeh
Ardeshir
A
Khalaf
Mohamed H
MH
Khatib
Sami
S
Kutoubi
Aghiad
A
Paydas
Semra
S
Elayoubi
Hanadi Rafii
HR
Zaatari
Ghazi
G
Zawam
Hamdy M
HM
Zelenetz
Andrew D
AD
D000352:Africa, Northern / Q000453:epidemiology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018912:Arabs / Q000706:statistics & numerical data*; D019317:Evidence-Based Medicine; D005710:Gallium Radioisotopes; D006689:Hodgkin Disease / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D015994:Incidence; D008223:Lymphoma / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis / Q000628:therapy; D008877:Middle East / Q000453:epidemiology; D049268:Positron-Emission Tomography; D014057:Tomography, X-Ray Computed; D014481:United States
D005710:Gallium Radioisotopes